Detecting adverse high-order drug combinations from individual case safety reports using computational statistics on disproportionality measures

Adverse drug reactions linked to the intake of drug combinations are a critical concern in pharmacovigilance, particularly as the controlled environment of clinical trials often lacks the scale and diversity to detect rare events involving multiple medications. While spontaneous reporting systems pr